Divigel (estradiol) / Sawai Pharma - LARVOL DELTA

Estrogen Hormone Products (clinicaltrials.gov) - P1 | N=8 | Completed | Sponsor: University of Maryland, Baltimore | Recruiting ➔ Completed | N=12 ➔ 8

Enrollment change • Trial completion

Estrogen Hormone Products (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: University of Maryland, Baltimore | Trial completion date: Jun 2025 ➔ Sep 2025 | Trial primary completion date: Jun 2025 ➔ Sep 2025

Trial completion date • Trial primary completion date

Estrogen Hormone Products (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: University of Maryland, Baltimore | Trial completion date: Mar 2025 ➔ Jun 2025 | Trial primary completion date: Mar 2025 ➔ Jun 2025

Trial completion date • Trial primary completion date

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome (clinicaltrials.gov) - P4 | N=50 | Recruiting | Sponsor: Aarhus University Hospital

New P4 trial • Endocrine Disorders • Genetic Disorders • Turners Syndrome

Drugs for menopausal symptoms. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal

"Are you the ones who make Divigel and keep me sane in menopause? 😂🤪" (@artformedicine)

Violet: Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women (clinicaltrials.gov) - P4; N=150; Recruiting; Sponsor: Scientific Research Institute of Public Health, Russian Federation

Clinical • Combination therapy • Monotherapy • New P4 trial

Thin endometrium problem in IVF programs. (PubMed, Gynecol Endocrinol) - "Estrogens improve the state of the endometrium and increase pregnancy rates in cases of thin endometrium in in vitro fertilization programs. The use of transdermal estrogens (Divigel, Orion Corporation, Finland) ensures an adequate increase in endometrial thickness and significantly lower estrogen doses."

Clinical • Journal • Gynecology

Drugs for menopausal symptoms. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal

REPLENISH: A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms (clinicaltrials.gov) - P3; N=1750; Active, not recruiting; Sponsor: TherapeuticsMD; Recruiting ➔ Active, not recruiting

Enrollment closed • Biosimilar

Estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms. (PubMed, Med Lett Drugs Ther) - No abstract available.

Journal

Colorectal cancer screening. (PubMed, Med Lett Drugs Ther) - No abstract available.

Journal